TGFB1 and cancer: Specifically, Schneider et al. [20] treated lung (A549) and breast (MDA-MB231) cancer cells with TGF-β to induce EMT and characterized phenotype changes with morphology assessment, F-actin and ZO-1 protein expression, and an ECIS device with an array of circular electrodes.